Icure Pharm. Inc. (KOSDAQ:A175250) announces a share repurchase program. Under the program, the company will repurchase up to 153,061 shares. The purpose of the program is to enhance the shareholder value through stabilization of stock price. The program is valid until September 8, 2019. As of August 7, 2019, the company had no shares in treasury within scope available for dividend and no shares in treasury through other repurchase.